Back
Zoetis Vs. Nektar Therapeutics Industry Stock Comparison
Sell
7
ZTS
Zoetis
Last Price:
$160.47
Seasonality Move:
3.07%
Sell
36
NKTR
Nektar Therapeutics
Last Price:
$0.94
Seasonality Move:
-1.1%
Sell
36
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $0.93. The Score for NKTR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $0.93The current trend is relatively stagnant and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
ZTS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.73 | Sell |
Relative Strength Index (14 RSI): | 39.79 | Sell |
Chaikin Money Flow: | 2338836 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (162.19 - 173.91) | Sell |
Bollinger Bands (100): | (165.33 - 185.13) | Sell |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 53.83 | Buy |
Chaikin Money Flow: | -952258 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.75 - 0.95) | Buy |
Bollinger Bands (100): | (0.88 - 1.28) | Sell |
ZTS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 162.7 | Sell |
20-day SMA: | 168.24 | Sell |
50-day SMA: | 167.96 | Sell |
200-day SMA: | 177.11 | Sell |
8-day EMA: | 161.8 | Sell |
20-day EMA: | 165.6 | Sell |
50-day EMA: | 168.83 | Sell |
200-day EMA: | 175.24 | Sell |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.9 | Buy |
20-day SMA: | 0.84 | Buy |
50-day SMA: | 0.92 | Buy |
200-day SMA: | 1.21 | Sell |
8-day EMA: | 0.92 | Buy |
20-day EMA: | 0.88 | Buy |
50-day EMA: | 0.93 | Sell |
200-day EMA: | 1.09 | Sell |
Zoetis Earnings Growth & ZTS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.26 per share, and an increase next year of $0.68 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.02 per share.
Zoetis Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |